 |
InterPro: IPR001330 Prenyltransferase/squalene oxidase
Additional Reading
|
|
Njoroge FG, Vibulbhan B, Pinto P, Strickland C, Bishop WR, Nomeir A, Girijavallabhan V.
Enhanced FTase activity achieved via piperazine interaction with catalytic zinc.
Bioorg. Med. Chem. Lett. 16 2006 984-8
[PubMed: 16298128]
http://dx.doi.org/10.1016/j.bmcl.2005.10.090
|
|
Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Horney C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH.
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.
Antimicrob. Agents Chemother. 51 2007 3659-71
[PubMed: 17606674]
http://dx.doi.org/10.1128/AAC.00246-07
|
|
Guo Z, Wu YW, Das D, Delon C, Cramer J, Yu S, Thuns S, Lupilova N, Waldmann H, Brunsveld L, Goody RS, Alexandrov K, Blankenfeldt W.
Structures of RabGGTase-substrate/product complexes provide insights into the evolution of protein prenylation.
EMBO J. 27 2008 2444-56
[PubMed: 18756270]
http://dx.doi.org/10.1038/emboj.2008.164
|
|
Guo Z, Wu YW, Tan KT, Bon RS, Guiu-Rozas E, Delon C, Nguyen TU, Wetzel S, Arndt S, Goody RS, Blankenfeldt W, Alexandrov K, Waldmann H.
Development of selective RabGGTase inhibitors and crystal structure of a RabGGTase-inhibitor complex.
Angew. Chem. Int. Ed. Engl. 47 2008 3747-50
[PubMed: 18399557]
|
|
Eastman RT, White J, Hucke O, Yokoyama K, Verlinde CL, Hast MA, Beese LS, Gelb MH, Rathod PK, Van Voorhis WC.
Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase.
Mol. Biochem. Parasitol. 152 2007 66-71
[PubMed: 17208314]
http://dx.doi.org/10.1016/j.molbiopara.2006.11.012
|
|
|
InterPro 23.1
|